Susana Torre Martínez
// Profesor/a Doctor/a NO Acreditado/a
Formación académica
| Nombre Titulación | Fecha | Entidad |
|---|---|---|
| Programa Oficial de Doctorado en Biotecnología | 20-03-2024 | Universidad Politécnica de Valencia |
| Master de Formación Permanente en Monitorización de Ensayos Clínicos y Desarrollo Farmacéutico | 03-09-2022 | INESEM |
| Certificat Universitari de Formació en Experimentació amb Animals Funció A+B+C+D | 01-07-2020 | FUNDACIÓN GENERAL DE LA UNIVERSITAT DE VALÈNCIA |
| Titulo Experto en Inmunología e Inmunoterapia en Cáncer | 30-06-2019 | Universidad Francisco de Vitoria |
| Máster Universitario en Formación del Profesorado ESO y Bachillerato, FP y Enseñanzas de Idiomas | 31-07-2018 | Universidad Miguel Hernández de Elche |
| Máster en Biotecnología Biomédica | 14-09-2017 | FUNDACION RECI-UNIVERSIDAD POLITECNICA DE VALENCIA |
| Graduado o Graduada en Biotecnología | 14-07-2015 | Universidad Miguel Hernández de Elche |
Dirección de tesis doctorales y/o proyectos fin de carrera
| Título proyecto | Tipo de proyecto | Fecha | Entidad |
|---|---|---|---|
| Estudio del papel de la Galectina-3 mediante CRISPR/Cas9 en modelos de co-cultivo tumor-estroma 3D | 07-07-2025 | Universitat Politècnica de València | |
| Análisis de biomarcadores no invasivos en melanoma cutáneo tratado con anticuerpos anti-PD-1: Un enfoque en la evaluación de resultados | 18-06-2025 | Universitat Politècnica de València | |
| Estudio de microambiente tumoral: Caracterización de la interacción entre CAFs y células tumorales en modelos 3D de cáncer de pulmón. | 23-07-2024 | Universidad Politécnica de Valencia |
Proyectos de I+D+i financiados en convocatorias competitivas de Administraciones o entidades públicas y privadas
| Título trabajo | Fecha | Autor/es |
|---|---|---|
| Descubriendo el papel de la Galectina-3 como una posible diana terapéutica en modelos complejos de cáncer de pulmón 3D. | 05-05-2025 | Susana Torres Martínez |
| IMPULSO: IMPacto de los niveles de ctDNA y la metilación en cáncer de PULmón KRAS-mutadO | 31-03-2025 | Cristina Caballero - Sandra Gallach Garcia - Lara Navarro Cerveró - Inma Hernández - Amaya Fernandez Díaz - Susana Torres Martínez - Silvia Calabuig Fariñas - Eloisa Jantus Lewintre - Ester Munera - Paula Espinosa Olarte |
| EPILUNAR:Epigenomic Profiling of Liquid Biopsy and Immunotherapy Resistance in Lung Cancer | 01-01-2025 | |
| Análisis del perfil de expresión inmune-periférico y su relación con la respuesta a inmunoterapia en cáncer de pulmón no microcítico. | 08-03-2024 | |
| Una nueva aproximación en inmunooncología de precisión: desarrollo de organoides tumorales derivados de pacientes de última generación. Hacia terapias personalizadas basadas en neoantígenos | 2023 | |
| INtegrative GENomic, digital Imaging and clinical information towars Precision Oncology Optimization – INGENIO | 01-01-2022 | |
| Nuevas Aproximaciones en la Oncología de Precisión: Modelos 3D (Organoides). | 2022 | - - - - - - - - - - - |
| Análisis de marcadores implicados en la resistencia al tratamiento con anticuerpos anti PD-1 mediante biopsia líquida en pacientes con melanoma estadio III-IV | 01-11-2021 | - - - - - - - - - |
| Beca SEOM +1. Análisis de marcadores implicados en la resistencia al tratamiento con anticuerpos anti PD-1 mediante biopsia líquida en pacientes con melanoma estadio III-IV | 2021 | - - - - - - - - - |
| Valoración del estado de inmunosenescencia en pacientes ancianos con cáncer de pulmón no células pequeña(CPNCP) tratados con inmunoterapia en función de su respuesta. | 2019 | Francisco Aparisi |
Contratos, convenios o proyectos de I+D+i no competitivos con Administraciones o entidades públicas o privadas
No pertenece a ningún grupo
Propiedad industrial e intelectual
No pertenece a ningún grupo
Publicaciones, documentos científicos y técnicos
| Título | Autores | Fecha | Tipo de producción | Tipo de soporte | Índice de impacto | Fuente de impacto | Cuartil | Doi/ISBN | Diagnostic and Prognostic Value of Angiogenic Status in Hereditary Hemorrhagic Telangiectasia | Sherlyne Jaimes-Díaz - Gustavo Juan-Samper - Susana Torres-Martínez - Eva Escorihuela-Alares - Silvia Calabuig-Fariñas - Raquel Rodríguez-López - Nieves Prieto-Colodrero - Mercedes Ramon-Capilla - Estrella Fernández-Fabrellas | 11-12-2024 | Artículo Científico | Revista | 3 | WOS (JCR) | N/A | Ver DOI | Circulating Immune Proteins: Improving the Diagnosis and Clinical Outcome in Advanced Non-Small Cell Lung Cancer | Susana Torres Martínez - Calabuig Fariñas - Marais Mosqueda - Sandra Gallach - Ester Munera Maravilla - Rafael Sirera - Lara Navarro - Ana Blasco - Carlos Camps - Eloisa Jantus Lewintre | 18-12-2023 | Artículo Científico | Revista | 5.6 | WOS (JCR) | N/A | Ver DOI | Soluble galectin-3 as a microenvironment-relevant immunoregulator with prognostic and predictive value in lung adenocarcinoma | S. Torres-Martínez - S. Calabuig-Fariñas - A. Moreno-Manuel - G. Bertolini - A. Herreros-Pomares - E. Escorihuela - E. Duréndez-Sáez - R. Guijarro - A. Blasco - L.Roz - C.Camps - E.Jantus-Lewintre | 11-08-2023 | Artículo Científico | Revista | 6.6 | WOS (JCR) | N/A | Ver DOI | Analysis of Exosomal Cargo Provides Accurate Clinical, Histologic and Mutational Information in Non-Small Cell Lung Cancer | Elena Duréndez-Sáez - Silvia Calabuig-Fariñas - Susana Torres-Martínez - Andrea Moreno-Manuel - Alejandro Herreros-Pomares - Eva Escorihuela - Marais Mosqueda - Sandra Gallach - Ricardo Guijarro - Eva Serna - Cristian Suárez-Cabrera - Jesús | 30-05-2022 | Artículo Científico | Revista | 5.2 | WOS (JCR) | N/A | Ver DOI | Programmed Death-Ligand 1 (PD-L1) as Immunotherapy Biomarker in Breast Cancer | Martín Núñez Abad - Silvia Calabuig-Fariñas - Miriam Lobo de Mena - Susana Torres-Martínez - Clara García González - José Ángel García García - Vega Iranzo González-Cruz - Carlos Camps Herrero | 08-01-2022 | Otros | Revista | 6.639 | WOS (JCR) | N/A | Ver DOI | Cancer Epigenetic Biomarkers in Liquid Biopsy for High Incidence Malignancies | Cora Palanca Ballester* - Aitor Rodriguez Casanova* - Susana Torres Martínez* - Silvia Calabuig Fariñas - Francisco Exposito - Diego Serrano - Esther Redin - Karmele Valencia - Eloisa Jantus Lewintre - Diaz Lagares - Luis Montuenga - Juan Sandova | 16-06-2021 | Otros | Revista | 6.639 | WOS (JCR) | N/A | Ver DOI | 3D printing novel in vitro cancer cell culture model systems for lung cancer stem cell study | Alejandro Herreros-Pomares - Xuan Zhou - Silvia Calabuig-Fariñas - Se-Jun Lee - Susana Torres - Timothy Esworthy - Sung Yun Hann - Eloísa Jantus-Lewintre - Carlos Camps - Lijie Grace Zhang | 09-01-2021 | Artículo Científico | Revista | 7.328 | WOS (JCR) | N/A | Ver DOI | Update on systemic treatment in early triple negative breast cancer. | Núñez Abad M - Calabuig-Fariñas S - Lobo de Mena M - José Godes Sanz de Bremond M - García González C - Torres Martínez S - García-García JÁ - Iranzo González-Cruz V - Camps Herrero C. | 2021 | Artículo Científico | Revista | 5.485 | WOS (JCR) | N/A | Ver DOI | Exosomal microRNAs in non-small cell lung cancer | Elena Duréndez Sáez* - Susana Torres Martinez* - Silvia Calabuig Fariñas - Marina Meri Abad - Macarena Ferrero Gimeno - Carlos Camps | 10-12-2020 | Otros | Revista | 1.241 | WOS (JCR) | N/A | Ver DOI | Profile on cobas® EGFR Mutation Test v2 as companion diagnostic with gefitinib in first-line treatment of patients with non-small cell lung cancer | Susana Torres - Álvaro González - Alberto Cunquero Tomás - Daniela Mirda - Silvia Calabuig Fariñas - Rafael Sirera - Eloisa Jantus Lewintre - Carlos Camps Herrero | 20-02-2020 | Otros | Revista | 5.225 | WOS (JCR) | N/A | Ver DOI | Passenger mutations in cancer evolution | Francisco Aparisi - Héctor Amado Labrador - Silvia Calabuig Fariñas - Susana Torres - Alejandro Herreros Pomares - Eloisa Jantus Lewintre - Ana Blasco - Vega Iranzo - Carlos Camps | 10-06-2019 | Otros | Revista | - | N/A | Ver DOI | Induction of viral interference by IPNV-carrier cells on target cells: A cell co-culture study | Ricardo Parreño - Susana Torres Martínez - Lucia Almagro - Melissa Belló Pérez - Amparo Estepa - Luis Pérez | 28-09-2016 | Artículo Científico | Revista | 3.44 | WOS (JCR) | N/A | Ver DOI |
|---|
Comités científicos, técnicos y/o asesores
No pertenece a ningún grupo
Trabajos presentados en congresos nacionales o internacionales
| Título del trabajo | Tipo evento | Nombre del congreso | Tipo de participación | Fecha de celebración |
|---|---|---|---|---|
| Exploring CAF–tumor interactions in 3D lung cancer co-culture models: CRISPR/Cas9- mediated study of the critical role of Galectin-3 in tumor–stroma crosstalk | Congreso | VII CIBERONC Young Researchers Meeting | Congresos | Participativo - Póster | 18-11-2025 |
| Circulating immune signatures as predictors of immunotherapy response in non-small cell lung cancer | Congreso | ISLB 2025 | Participativo - Póster | 01-11-2025 |
| Clinical Utility of Soluble Immune Mediators and cfDNA in Endometrial Cancer | Congreso | ISLB 2025 | Participativo - Ponencia oral (comunicación oral) | 01-11-2025 |
| Exploring the Impact of Peripheral Immune Landscape on Immunotherapy Outcomes in Non-Small Cell Lung Cancer | IASLC 2025 World Conference on Lung Cancer | Otros | 06-09-2025 | |
| Holistic Liquid Biopsy assessment in Lung Cancer patients | Jornada | Workshop of CIBERONC Work Modules | Participativo - Ponencia oral (comunicación oral) | 26-11-2024 |
| A first-line approach: Liquid biopsy-guided osimertinib therapy for EGFRmutated NSCLC | Congreso | ISLB 2024 Congress | Participativo - Póster | 23-11-2024 |
| Assessing mutational status in NSCLC through exosomal liquid biopsies | Congreso | ISLB 2024 Congress | Participativo - Póster | 23-11-2024 |
| NSCLC exosomes: Unlocking biomarker potential | Congreso | ISLB 2024 Congress | Participativo - Póster | 23-11-2024 |
| Non-invasive immunogram to characterize and monitor immune status in non-small cell lung cancer patients treated with immunotherapy | Congreso | ISLB 2024 Congress | Participativo - Póster | 23-11-2024 |
| Liquid biopsy for monitoring response in KRAS-mutated NSCLC patients treated with first-line immunotherapy | ISLB 2024 Congress | Participativo - Póster | 23-11-2024 | |
| Development of next-generation tumor organoids derived from non-small cell lung cancer patients | Congreso | 19th ASEICA International Congress | Participativo - Póster | 13-11-2024 |
| Exploring CAF-tumor cell interactions within 3D lung cancer models to elucidate the critical role of Galectin-3 in cancer | Congreso | 19th ASEICA International Congress | Participativo - Póster | 13-11-2024 |
| MARCADORES ANGIOGÉNICO EN PACIENTES CON TELANGIECTASIA HEMORRÁGICA HEREDITARIA (THH). VALOR DIAGNÓSTICO Y PRONÓSTICO | Congreso | 57º Congreso Nacional de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR) | Participativo - Póster | 06-06-2024 |
| Prognostic and Predictive Non-Invasive Biomarkers in Cutaneous Melanoma Treated With Anti PD-1 Antibodies | Congreso | 5th Annual Congress Liquid Biopsy | Participativo - Póster | 19-11-2023 |
| GALECTIN-3 AS A MICROENVIRONMENT-RELEVANT IMMUNOREGULATOR THROUGH REGULATORY T CELLS IN LUNG ADENOCARCINOMA PATIENTS | Congreso | VI Young Researchers Meeting of CIBERONC/OBN | Participativo - Ponencia oral (comunicación oral) | 06-11-2023 |
| Exploring tumor micronvironment in lung cancer through patient-derived 3D models | Congreso | ESMO 2023 | Participativo - Póster | 20-10-2023 |
| Real-world results of Homologous Recombination Deficiency testing. Comparison between two methods on 2,655 ovarian cancer patients in Spain | Congreso | ESMO 2023 | Participativo - Póster | 20-10-2023 |
| IDENTIFICACIÓN DE BIOMARCADORES NO INVASIVOS EN CÁNCER DE MAMA TRIPLE NEGATIVO (CMTN) PRECOZ EN PACIENTES TRATADAS CON QUIMIOTERAPIA NEOADYUVANTE (QTN) | Congreso | SEOM 2023 | Participativo - Ponencia oral (comunicación oral) | 19-09-2023 |
| VALOR PRONÓSTICO DE VARIABLES CLÍNICAS E INMUNOHISTOQUÍMICAS EN CÁNCER DE MAMA TRIPLE NEGATIVO (CMTN) PRECOZ TRATADO CON QUIMIOTERAPIA NEOADYUVANTE (QTN) | Congreso | SEOM 2023 | Participativo - Póster | 19-09-2023 |
| Optimization of extracellular matrices as an alternative to Matrigel for Patient Derived Tumor Organoids (PDTO) development | Jornada | Jornada La SEBBM y la Bioquímica valenciana | Participativo - Póster | 06-06-2023 |
| 3D CO-CULTURE MODELS OF LUNG CANCER TUMORSPHERES AND CANCER ASSOCIATED FIBROBLASTS: FIRST APPROACH TO STUDY THEIR INTERACTIONS | Jornada | Jornada La SEBBM y la Bioquímica valenciana | Participativo - Póster | 02-06-2023 |
| 3D CO-CULTURE MODELS OF LUNG CANCER TUMORSPHERES AND CANCER ASSOCIATED FIBROBLASTS: FIRST APPROACH TO STUDY THEIR INTERACTIONS | Jornada | Workshop Workmodules: Immuno-Oncology, Experimental Models and Liquid Biopsy | Participativo - Ponencia oral (comunicación oral) | 25-05-2023 |
| Optimization of extracellular matrices as an alternative to Matrigel for Patient Derived Tumor Organoids (PDTO) development. | Jornada | Workshop Workmodules: Immuno-Oncology, Experimental Models and Liquid Biopsy | Participativo - Póster | 25-05-2023 |
| Prognostic and predictive non-invasive biomarkers in early Triple Negative Breast Cancer (TNBC) treated with neoadjuvant chemotherapy (NACT) | Congreso | Workshop Workmodules: Immuno-Oncology, Experimental Models and Liquid Biopsy | Participativo - Póster | 2023 |
| Prognostic and predictive non-invasive biomarkers in early Triple negative breast cancer (TNBC) treated with neoadjuvant chemotherapy (NACT) | Congreso | ESMO Breast Cancer Congress 2023 | Participativo - Póster | 2023 |
| Prognostic value of tumor infiltrating lymphocytes (TILs) and soluble inmune checkpoints in early triple negative breast cancer (TNBC) | Congreso | ESMO Breast Cancer 2023 | Participativo - Póster | 2023 |
| Prognostic value tumor-infiltrating lymphocytes and soluble immune checkpoints in early triple negative breast cancer | Congreso | Workshop Workmodules: Immuno-Oncology, Experimental Models and Liquid Biopsy | Participativo - Póster | 2023 |
| ASSESSMENT OF CD5 AND CD6 EXPRESSION LEVELS IN PBMCS AS POTENTIAL BIOMARKERS IN ADVANCED-STAGE NSCLC PATIENTS TREATED WITH IMMUNOTHERAPY | Congreso | V YOUNG RESEARCHERS MEETING | Participativo - Ponencia oral (comunicación oral) | 2022 |
| ASSESSMENT OF CD5 AND CD6 EXPRESSION LEVELS IN PBMCs AS POTENTIAL BIOMARKERS IN ADVANCED-STAGE NSCLC PATIENTS TREATED WITH IMMUNOTHERAPY | Congreso | 4th Annual Congress Liquid Biopsy | Participativo - Póster | 2022 |
| ASSESSMENT OF CD5 AND CD6 EXPRESSION LEVELS IN PERIPHERAL BLOOD MONONUCLEAR CELLS AS POTENTIAL BIOMARKERS IN ADVANCEDSTAGE NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH IMMUNOTHERAPY | Congreso | XI Educational Symposium of the Spanish Lung Cancer Group | Participativo - Póster | 2022 |
| Analysis of TCR-β Repertoire Analysis to Identify Predictive and Prognostic Biomarkers in Non-Small Cell Lung Cancer Patients Treated with Anti-PD1 | Congreso | 4th Annual Congress Liquid Biopsy | Participativo - Póster | 2022 |
| Analysis of soluble markers as predictive biomarkers to neoadjuvant chemotherapy in early triple-negative breast cancer (TNBC) | Congreso | VII SIMPIOSIO DE BIOPSIA LÍQUIDA | Participativo - Ponencia oral (comunicación oral) | 2022 |
| Assesment of CD5 and CD6 expression levels in PBMCs as potential biomarkers in advanced-stage NSCLC patients treated with inmunotherapy | Congreso | 18th ASEICA International Congress, | Participativo - Póster | 2022 |
| Detection of PI3KCA Gene Mutations by NGS in Cellfree DNA in Patients with a Clinical Diagnosis of PROS Syndrome | Congreso | 4th Annual Congress Liquid Biopsy | Participativo - Póster | 2022 |
| Soluble Immune-related Factors are Associated with Response to Neoadjuvant Chemotherapy in Triplenegative Breast Cance | Congreso | 4th Annual Congress Liquid Biopsy | Participativo - Póster | 2022 |
| Soluble Inmune-related Factors are Associated with Response to Neoadjuvant Chemotherapyin Triple-negative Breast Cancer | Congreso | 18th ASEICA International Congress | Participativo - Póster | 2022 |
| Soluble immune-related factors are associated with response to neoadjuvant chemotherapy in triple-negative breast cancer | Congreso | V YOUNG RESEARCHERS MEETING | Participativo - Póster | 2022 |
| Study of LAG3 and HVEM combination as soluble predictive and prognostic biomarker to second-line immunotherapy treatment in advanced Non-Small Cell Lung Cancer (NSCLC) | Congreso | VII SIMPOSIO DE BIOPSIA LÍQUIDA | Participativo - Ponencia oral (comunicación oral) | 2022 |
| Study of soluble markers as predictive and prognostic biomarkers to immunotherapy with pembrolizumab in first-line treatment of advanced Non-Small Cell Lung Cancer (NSCLC) | Congreso | VII SIMPOSIO DE BIOPSIA LÍQUIDA | Participativo - Ponencia oral (comunicación oral) | 2022 |
| TCR-β REPERTOIRE ANALYSIS AS A TOOL TO IDENTIFY PREDICTIVE AND PROGNOSTIC BIOMARKERS IN NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH ANTI-PD1 | Congreso | XI Educational symposium of the Spanish Lung Cancer Group | Participativo - Póster | 2022 |
| TCR-β repertoire analysis to identify predictive and prognostic biomarkers in NOn-Small Cell Ling Cancer patients treated with anti PD-1 | Congreso | 18th ASEICA International Congress | Participativo - Póster | 2022 |
| TCR-β repertoire analysis to identify predictive and prognostic biomarkers in Non-Small Cell Lung Cancer patients treated with anti-PD1 | Congreso | V YOUNG RESEARCHERS MEETING | Participativo - Póster | 2022 |
| UTILITY OF LIQUID BIOPSY MONITORING IN EGFR-MUTATED NSCLC PATIENTS TREATED IN FIRST-LINE WITH OSIMERTINIB | Congreso | 4th Annual Congress Liquid Biopsy | Participativo - Póster | 2022 |
| sGalectin -3, sIL-10; sMIP3a and sIL 13 as Prognostic Biomarkers in Triple-negative Breast Cancer | Congreso | 18th ASEICA International Congress | Participativo - Póster | 2022 |
| sGalectin-3, sIL-10, sMIP3a and sIL13 as Prognostic Biomarkers in Triple-negative Breast Cancer | Congreso | 4th Annual Congress Liquid Biopsy, | Participativo - Póster | 2022 |
| sGalectin-3, sIL-10, sMIP3a and sIL13 as prognostic biomarkers in triple-negative breast cancer | Congreso | V YOUNG RESEARCHERS MEETING | Participativo - Póster | 2022 |
| GAL3 AS AN IMMUNOSUPRESSIVE REGULATOR IN LUNG CANCER STEMNESS. PROGNOSTIC AND PREDICTIVE IMPLICATIONS IN NSCLC | IV Young Researchers Meeting | Participativo - Póster | 13-12-2021 | |
| STUDY OF SOLUBLE MARKERS AS PREDICTIVE AND PROGNOSTIC BIOMARKERS TO IMMUNOTHERAPY WITH PEMBROLIZUMAB IN ADVANCED NON-SMALL CELL LUNG CANCER | IV Young Researchers Meeting | Participativo - Póster | 13-12-2021 | |
| Gal-3 as a immunosuppressive regulator in lung cancer stemness. Prognostic and predictive implications in NSCLC | Congreso | 14th Congress on Lung Cancer | Participativo - Ponencia oral (comunicación oral) | 10-11-2021 |
| STUDY OF SOLUBLE MARKERS AS PREDICTIVE AND PROGNOSTIC BIOMARKERS TO IMMUNOTHERAPY WITH PEMBROLIZUMAB IN ADVANCED NON-SMALL CELL LUNG CANCER | Congreso | 14th Congress on Lung Cancer | Participativo - Ponencia oral (comunicación oral) | 10-11-2021 |
| Liquid biopsy monitoring enhances early detection of resistances to first line osimertinib treatment in NSCLC patients | 14th Congress on Lung Cancer | Participativo - Póster | 10-11-2021 | |
| NGS USING LIQUID BIOPSY AS A TOOL TO IDENTIFY TARGETABLE ALTERATIONS IN NSCLC | 14th Congress on Lung Cancer | Participativo - Ponencia oral (comunicación oral) | 10-11-2021 | |
| Analysis of soluble markers as predictive biomarkers to neoadjuvant chemotherapy in early triple-negative breast cancer (TNBC) | Congreso | III ISLB ANNUAL VIRTUAL CONGRESS 2021 | Participativo - Póster | 22-10-2021 |
| Combination of LAG3 and HVEM as a predictive biomarker to second-line immunotherapy treatment in advanced Non-Small Cell Lung Cancer (NSCLC) patients | Congreso | III ISLB ANNUAL VIRTUAL CONGRESS 2021 | Participativo - Póster | 22-10-2021 |
| Liquid biopsy monitoring allows detection of disease progression in EGFR-mutated NSCLC patients treated in first-line with Osimertinib | Congreso | III ISLB ANNUAL VIRTUAL CONGRESS 2021 | Participativo - Póster | 22-10-2021 |
| Study of soluble markers as predictive and prognostic biomarkers to immunotherapy with pembrolizumab in first line treatment of advanced Non-Small Cell Lung Cancer (NSCLC) | Congreso | III ISLB ANNUAL VIRTUAL CONGRESS 2021 | Participativo - Póster | 22-10-2021 |
| Targeted NGS using liquid biopsy to perform molecular diagnosis and patient monitoring in NSCLC | Congreso | III ISLB ANNUAL VIRTUAL CONGRESS 2021 | Participativo - Póster | 22-10-2021 |
| Inmunomodulación en cáncer de mama triple negativo (CMTN) precoz. Análisis de biomarcadores solubles predictivos de respuesta a quimioterapia neoadyuvante en CMTN. | SEOM 2021 Virtual | Participativo - Póster | 22-10-2021 | |
| ANALYSIS OF PLASMA BIOMARKERS AS PREDICTIVE AND PROGNOSTIC BIOMARKERS TO IMMUNOTHERAPY WITH FIRST-LINE PEMBROLIZUMAB IN ADVANCED NON-SMALL CELL LUNG CANCER | Congreso | 3rd ASEICA Educational Symposium | Participativo - Póster | 2021 |
| Immunomodulation in early triple-negative breast cancer (TNBC): Analysis of soluble markers as predictive biomarkers to neoadjuvant chemotherapy in TNBC | Congreso | ESMO Congress 2021 | Participativo - Ponencia oral (comunicación oral) | 2021 |
| PLASMA LAG3-HVEM COMBINATION AS PREDICTIVE AND PROGNOSTIC BIOMARKER TO SECOND-LINE IMMUNOTHERAPY TREATMENT IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) | Congreso | 3rd ASEICA Educational Symposium | Participativo - Póster | 2021 |
| Predictive and prognostic value of soluble biomarkers in advanced Non-Small-Cell Lung Cancer (NSCLC) patients treated with anti-PD1/PDL1. | Congreso | VI Simposio Biopsia Líquida | Participativo - Ponencia oral (comunicación oral) | 2021 |
| STUDY OF GAL3 AS AN IMMUNOREGULATOR IN LUNG CANCER STEMNESS. PROGNOSTIC AND PREDICTIVE IMPLICATIONS IN NSCLC. | Congreso | 3rd ASEICA Educational Symposium | Participativo - Póster | 2021 |
| Analysis of predictive and prognostic soluble biomarkers in advanced Non-Small Cell Lung Cancer (NSCL) patients treated with anti-PD1/PDL1 | III Young Researchers Meeting from CIBERONC 2020 | Participativo - Póster | 23-12-2020 | |
| Characterization of immunobiological properties of lung tumorspheres in NSCLC | Congreso | III Young Researchers Meeting from CIBERONC 2020 | Participativo - Póster | 14-12-2020 |
| Identification of targetable alterations using NGS-based liquid biopsy in NSCLC patients | Congreso | III Young Researchers Meeting from CIBERONC 2020 | Participativo - Póster | 14-12-2020 |
| ANALYSIS OF IMMUNOBIOLOGICAL PROPERTIES OF LUNG TUMORSPHERES IN NSCLC | Congreso | X Educational Symposium of the spanish lung cancer group | Participativo - Ponencia oral (comunicación oral) | 25-11-2020 |
| Identification of New Biomarkers in Non-Small Cell Lung Cancer (NSCLC) by Analyzing Exosomes Cargo | Congreso | IASLC 2020 Hot Topic Meeting: Liquid Biopsy | Participativo - Póster | 28-08-2020 |
| NGS-Based Liquid Biopsy as a Non-Invasive Tool to Identify Targetable Alterations in Non-Small-Cell Lung Cancer (NSCLC) Patients | Congreso | IASLC 2020 Hot Topic Meeting: Liquid Biopsy | Participativo - Póster | 28-08-2020 |
| Predictive and prognostic role of soluble biomarkers in advanced Non-Small Cell Lung Cancer (NSCL) patients treated with anti-PD1/PDL1 immunotherapy | Congreso | IASLC 2020 Hot Topic Meeting: Liquid Biopsy | Participativo - Póster | 28-08-2020 |
| NEXT GENERATION SEQUENCING USING LIQUID BIOPSIES: A NON-INVASIVE TOOL THAT ALLOWS IDENTIFICATION OF TARGETABLE ALTERATIONS IN LUNG CANCER PATIENTS | 2nd ASEICA EDUCATIONAL SYMPOSIUM | Participativo - Ponencia oral (comunicación oral) | 29-11-2019 | |
| Analysis of immunoregulatory factors produced by lung tumorspheres: Galectin-3 as immune modulator with prognostic value in NSCLC adenocarcinoma | Congreso | 2nd ASEICA EDUCATIONAL SYMPOSIUM | Participativo - Póster | 28-11-2019 |
| Analysis of immunoregulatory factors produced by lung tumorspheres: Galectin-3 as immune modulator with prognostic value in NSCLC adenocarcinoma | Congreso | II Encuentro de Jóvenes Investigadores CIBERONC | Participativo - Póster | 27-11-2019 |
| Analysis of immunoregulatory factors produced by lung tumorspheres: Galectin-3 as immune modulator with prognostic value in NSCLC adenocarcinoma | Congreso | 13th Congress on Lung Cancer | Participativo - Póster | 21-11-2019 |
| Análisis de factores inmunosupresores producidos por tumoresferas. Galectina-3 como modulador inmune con valor pronóstico en adenocarcinoma de pulmón. | Congreso | SEOM 2019 | Participativo - Ponencia oral (comunicación oral) | 22-10-2019 |
| Analysis of immunosuppressive factors produced by tumorspheres in NSCLC. Prognostic value of Galectin-3 in adenocarcinoma | Congreso | ESMO Congress 2019 | Participativo - Póster | 27-09-2019 |
| Exosomes in NSCLC as a source of biomarkers | Congreso | ESMO Congress 2019 | Participativo - Póster | 27-09-2019 |
| Analysis of immunosuppressive factors produced by CSCs revealed Galectin-3 as immune modulator with prognostic value in NSCLC adenocarcinoma | Congreso | IALSC World Conference on Lung Cancer 2019 | Participativo - Póster | 07-09-2019 |
| STUDY OF EXOSOMES IN NSCLC FOR BIOMARKERS SEARCHING | Congreso | IALSC World Conference on Lung Cancer 2019 | Participativo - Póster | 07-09-2019 |
| Soluble biomarker signature to predict outcome of patients with Non-Small-Cell lung cancer (NSCLC) treated with anti-PD1/PDL1 monoclonal antibodies. | Congreso | ASCO Annual Meeting | Participativo - Póster | 31-05-2019 |
| Lung tumorsheres as a drug screening platform against cancer stem cells | Congreso | ELCC (European Lung Cancer Congress) | Participativo - Póster | 10-04-2019 |
| Interactions of cancer stem cell and immune microenvironment in non-small cell lung cancer (NSCLC) | Congreso | 11as JORNADAS DE FORMACIÓN CIBERES / CIBERONC 2018 | Participativo - Póster | 15-11-2018 |
| Interactions of cancer stem cell and immune microenvironment in non-small cell lung cancer (NSCLC) | Congreso | 16th ASEICA INTERNATIONAL CONGRESS | Participativo - Póster | 06-11-2018 |
| Interactions of cancer stem cell and immune microenvironment in non-small cell lung cancer (NSCLC) | Congreso | ESMO 2018 Congress | Participativo - Póster | 19-10-2018 |
| Interacción entre las células madre tumorales (CMTs) y el microambiente inmune del cáncer de pulmón no microcítico (CPNM) | Congreso | SEOM (Sociedad Española de Oncología Médica) | Participativo - Póster | 25-09-2018 |
| Characterization of immune microenvironment in cancer stem cells in non-small cell lung cancer. Analysis of immunosuppressive and immunoregulatory factors. | Congreso | II REUNION GENERAL DE CIBERONC | Participativo - Póster | 02-02-2018 |
| Characterization of immune microenvironment in cancer stem cells in non-small cell lung cancer. Analysis of immunosuppressive and immunoregulator factors | Congreso | 1st ASEICA Educational Symposium | Participativo - Póster | 14-11-2017 |
| Análisis de marcadores y vías de señalización de células madre tumorales en tumoresferas de cáncer de pulmón no microcítico | Congreso | SEOM (Sociedad Española de Oncología Médica) | Participativo - Póster | 24-10-2017 |
| Caracterización del microambiente tumoral. análisis pronóstico de marcadores inmunologicos en pacientes con cáncer de pulmón no microcítico en estadios resecable | Congreso | SEOM (Sociedad Española de Oncología Médica) | Participativo - Póster | 24-10-2017 |
| Establecimiento de una firma de genes inmunoreguladores con valor pronóstico en estadios tempranos de adenocarcinomas de pulmón | Congreso | SEOM (Sociedad Española de Oncología Médica) | Participativo - Póster | 24-10-2017 |
| Characterization of cancer stem cell and immune microenvironment interactions in non-small cell lung cancer (NSCL) | Congreso | ESMO 2017 Congres | Participativo - Póster | 08-09-2017 |
| Gene characterization of lung-tumorspheres for their usage as an in vitro screening platform for testing new therapeutic strategies | Congreso | AACR Annal Meeting | Participativo - Póster | 01-04-2017 |
Organización de actividades de I+D+i
| Título de la actividad | Entidad convocante | Fecha de inicio | Fecha de finalización |
|---|---|---|---|
| V YOUNG RESEARCHERS MEETING | CIBERONC | 14-11-2022 | - |
Gestión de I+D+i
No pertenece a ningún grupo